Impact of endocrine-disrupting compounds (EDCs) on female reproductive health

Paul AF Fowler, M Bellingham, K. D. Sinclair, N. P. Evans, P Pocar, B Fischer, K Schaedlich, S-J Schmidt, Maria R Amezaga, Siladitya Bhattacharya, S. M. Rhind, P. J. O'Shaughnessy

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Evidence is accumulating that environmental chemicals (ECs) including endocrine-disrupting compounds (EDCs) can alter female reproductive development, fertility and onset of menopause. While not as clearly defined as in the male, this set of abnormalities may constitute an Ovarian Dysgenesis Syndrome with at least some origins of the syndrome arising during foetal development. ECs/EDCs have been shown to affect trophoblast and placental function, the female hypothalamo-pituitary–gonadal axis, onset of puberty and adult ovarian function. The effects of ECs/EDCs are complex, not least because it is emerging that low-level, ‘real-life’ mixtures of ECs/EDCs may carry significant biological potency. In addition, there is evidence that ECs/EDCs can alter the epigenome in a sexually dimorphic manner, which may lead to changes in the germ line and perhaps even to transgenerational effects. This review summarises the evidence for EC, including EDC, involvement in female reproductive dysfunction, it highlights potential mechanisms of EC action in the female and emphasises the need for further research into EC effects on female development and reproductive function.

Original languageEnglish
Pages (from-to)231-239
Number of pages9
JournalMolecular and Cellular Endocrinology
Volume355
Issue number2
Early online date28 Oct 2011
DOIs
Publication statusPublished - May 2012

Fingerprint

Endocrine Disruptors
Reproductive Health
Health
Pharmacologic Actions
Trophoblasts
Puberty
Menopause
Fetal Development
Germ Cells
Fertility
Research

Keywords

  • female
  • reproduction
  • endocrine disrupting compounds
  • development
  • ovary dysgenesis syndrome
  • pregnancy

Cite this

Fowler, P. AF., Bellingham, M., Sinclair, K. D., Evans, N. P., Pocar, P., Fischer, B., ... O'Shaughnessy, P. J. (2012). Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Molecular and Cellular Endocrinology, 355(2), 231-239. https://doi.org/10.1016/j.mce.2011.10.021

Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. / Fowler, Paul AF; Bellingham, M; Sinclair, K. D.; Evans, N. P.; Pocar, P; Fischer, B ; Schaedlich, K; Schmidt, S-J; Amezaga, Maria R; Bhattacharya, Siladitya; Rhind, S. M.; O'Shaughnessy, P. J.

In: Molecular and Cellular Endocrinology, Vol. 355, No. 2, 05.2012, p. 231-239.

Research output: Contribution to journalArticle

Fowler, PAF, Bellingham, M, Sinclair, KD, Evans, NP, Pocar, P, Fischer, B, Schaedlich, K, Schmidt, S-J, Amezaga, MR, Bhattacharya, S, Rhind, SM & O'Shaughnessy, PJ 2012, 'Impact of endocrine-disrupting compounds (EDCs) on female reproductive health', Molecular and Cellular Endocrinology, vol. 355, no. 2, pp. 231-239. https://doi.org/10.1016/j.mce.2011.10.021
Fowler, Paul AF ; Bellingham, M ; Sinclair, K. D. ; Evans, N. P. ; Pocar, P ; Fischer, B ; Schaedlich, K ; Schmidt, S-J ; Amezaga, Maria R ; Bhattacharya, Siladitya ; Rhind, S. M. ; O'Shaughnessy, P. J. / Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. In: Molecular and Cellular Endocrinology. 2012 ; Vol. 355, No. 2. pp. 231-239.
@article{19cf1ac364414fd68f0d5b4996519b0b,
title = "Impact of endocrine-disrupting compounds (EDCs) on female reproductive health",
abstract = "Evidence is accumulating that environmental chemicals (ECs) including endocrine-disrupting compounds (EDCs) can alter female reproductive development, fertility and onset of menopause. While not as clearly defined as in the male, this set of abnormalities may constitute an Ovarian Dysgenesis Syndrome with at least some origins of the syndrome arising during foetal development. ECs/EDCs have been shown to affect trophoblast and placental function, the female hypothalamo-pituitary–gonadal axis, onset of puberty and adult ovarian function. The effects of ECs/EDCs are complex, not least because it is emerging that low-level, ‘real-life’ mixtures of ECs/EDCs may carry significant biological potency. In addition, there is evidence that ECs/EDCs can alter the epigenome in a sexually dimorphic manner, which may lead to changes in the germ line and perhaps even to transgenerational effects. This review summarises the evidence for EC, including EDC, involvement in female reproductive dysfunction, it highlights potential mechanisms of EC action in the female and emphasises the need for further research into EC effects on female development and reproductive function.",
keywords = "female, reproduction, endocrine disrupting compounds, development, ovary dysgenesis syndrome, pregnancy",
author = "Fowler, {Paul AF} and M Bellingham and Sinclair, {K. D.} and Evans, {N. P.} and P Pocar and B Fischer and K Schaedlich and S-J Schmidt and Amezaga, {Maria R} and Siladitya Bhattacharya and Rhind, {S. M.} and O'Shaughnessy, {P. J.}",
note = "Copyright {\^A}{\circledC} 2011. Published by Elsevier Ireland Ltd.",
year = "2012",
month = "5",
doi = "10.1016/j.mce.2011.10.021",
language = "English",
volume = "355",
pages = "231--239",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Impact of endocrine-disrupting compounds (EDCs) on female reproductive health

AU - Fowler, Paul AF

AU - Bellingham, M

AU - Sinclair, K. D.

AU - Evans, N. P.

AU - Pocar, P

AU - Fischer, B

AU - Schaedlich, K

AU - Schmidt, S-J

AU - Amezaga, Maria R

AU - Bhattacharya, Siladitya

AU - Rhind, S. M.

AU - O'Shaughnessy, P. J.

N1 - Copyright © 2011. Published by Elsevier Ireland Ltd.

PY - 2012/5

Y1 - 2012/5

N2 - Evidence is accumulating that environmental chemicals (ECs) including endocrine-disrupting compounds (EDCs) can alter female reproductive development, fertility and onset of menopause. While not as clearly defined as in the male, this set of abnormalities may constitute an Ovarian Dysgenesis Syndrome with at least some origins of the syndrome arising during foetal development. ECs/EDCs have been shown to affect trophoblast and placental function, the female hypothalamo-pituitary–gonadal axis, onset of puberty and adult ovarian function. The effects of ECs/EDCs are complex, not least because it is emerging that low-level, ‘real-life’ mixtures of ECs/EDCs may carry significant biological potency. In addition, there is evidence that ECs/EDCs can alter the epigenome in a sexually dimorphic manner, which may lead to changes in the germ line and perhaps even to transgenerational effects. This review summarises the evidence for EC, including EDC, involvement in female reproductive dysfunction, it highlights potential mechanisms of EC action in the female and emphasises the need for further research into EC effects on female development and reproductive function.

AB - Evidence is accumulating that environmental chemicals (ECs) including endocrine-disrupting compounds (EDCs) can alter female reproductive development, fertility and onset of menopause. While not as clearly defined as in the male, this set of abnormalities may constitute an Ovarian Dysgenesis Syndrome with at least some origins of the syndrome arising during foetal development. ECs/EDCs have been shown to affect trophoblast and placental function, the female hypothalamo-pituitary–gonadal axis, onset of puberty and adult ovarian function. The effects of ECs/EDCs are complex, not least because it is emerging that low-level, ‘real-life’ mixtures of ECs/EDCs may carry significant biological potency. In addition, there is evidence that ECs/EDCs can alter the epigenome in a sexually dimorphic manner, which may lead to changes in the germ line and perhaps even to transgenerational effects. This review summarises the evidence for EC, including EDC, involvement in female reproductive dysfunction, it highlights potential mechanisms of EC action in the female and emphasises the need for further research into EC effects on female development and reproductive function.

KW - female

KW - reproduction

KW - endocrine disrupting compounds

KW - development

KW - ovary dysgenesis syndrome

KW - pregnancy

U2 - 10.1016/j.mce.2011.10.021

DO - 10.1016/j.mce.2011.10.021

M3 - Article

VL - 355

SP - 231

EP - 239

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 2

ER -